The regulation of NLR and RLR‐driven NF‐κB signalling by E3 ligases has not been clearly described in cancer; however, a few studies have demonstrated the cancer implication of E3 ligase regulation of NOD1/2‐driven NF‐κB signalling. The gene discussed is NFKB1; the disease is cancer.